Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial

Sex: All

Ages: 20 Years – 35 Years

Healthy volunteers: 1

Phase: NA

Enrollment: 16

Sponsor: Rigshospitalet, Denmark

Summary

This study aims to investigate whether octreotide, a medication used off-label to treat chylothorax, has a direct effect on human lymphatic drainage. To study the effects of octreotide, the researchers conducted a pre-clinical experiment using human lymphatic vessels mounted in a myograph chamber and a clinical experiment in which a double-blinded, randomized, cross-over trial wass conducted in 16 healthy adults. The results of the study will be used to determine the role of octreotide in the treatment of chylothorax and other lymphatic disorders.

Eligibility Criteria

Inclusion Criteria:HealthyExclusion Criteria:No daily medication (except birth control), or allergies towards contrast agents.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05683444). StuddyBuddy aggregates publicly available trial information.